Does ENZALUTAMIDE Cause Subdural haematoma? 70 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Subdural haematoma have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.1% of all adverse event reports for ENZALUTAMIDE.
70
Reports of Subdural haematoma with ENZALUTAMIDE
0.1%
of all ENZALUTAMIDE reports
28
Deaths
49
Hospitalizations
How Dangerous Is Subdural haematoma From ENZALUTAMIDE?
Of the 70 reports, 28 (40.0%) resulted in death, 49 (70.0%) required hospitalization, and 5 (7.1%) were considered life-threatening.
Is Subdural haematoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 70 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Subdural haematoma?
RIVAROXABAN (1,423)
ASPIRIN (1,181)
APIXABAN (1,025)
WARFARIN (1,012)
CLOPIDOGREL BISULFATE (809)
DABIGATRAN ETEXILATE (648)
IBRUTINIB (342)
HEPARIN (201)
ENOXAPARIN (156)
CYCLOPHOSPHAMIDE (146)
Which ENZALUTAMIDE Alternatives Have Lower Subdural haematoma Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE